Sunwin International Neutraceuticals Signs Exclusive - 500 Beiträge pro Seite

[V51]

S1N

(PR NEWSWIRE) Sunwin International Neutraceuticals Signs Exclusive Distribution
Agreement with Hunan Fuhui Flavors
Sunwin International Neutraceuticals Signs Exclusive Distribution Agreement with
Hunan Fuhui Flavors

QUFU, China, Oct. 8 /PRNewswire-FirstCall/ - Sunwin International Neutraceutica
ls, Inc. (OTCBB: SUWN), one of the world's leading producers of all-natural, zer
o-calorie stevia in China and a leader in the production and distribution of Chi
nese herbs and veterinary medicines announced today it has signed an exclusive d
istribution agreement with Hunan Fuhui Flavors Co. Ltd. to distribute Sunwin's s
tevia extract within Hunan province in China.
Under the terms of the one year agreement, Sunwin will provide marketing suppor
t and technical staff to support Hunan Fuhui's sales efforts within the province
. Additionally, Hunan Fuhui must distribute at least 50 tons of stevia extract w
ithin the first year for this agreement to be subject to renewal. Hunan Fuhui is
an experienced distributor based in the Hunan province, located in southern Chi
na and home to more than 64 million people.
Commenting on the agreement, Chairman Laiwang Zhang stated, "We are pleased to
secure a strong partner in Hunan Fuhui, whose expertise as a regional distributo
r makes them an ideal candidate to increase Sunwin's presence in Hunan province
where stevia is commonly used as a natural sweetener. We have recently completed
a number of expansion programs to increase our total stevia production capacity
and we are particularly excited to expand our marketing efforts in this importa
nt domestic market. We look forward to this new partnership as we continue pursu
e opportunities both in China and throughout the globe to expand revenue and pro
fits in our stevia operations."

Company Background

Sunwin International Neutraceuticals, Inc. engages in the areas of essential tr
aditional Chinese medicine, zero calorie natural sweeteners (stevia), and veteri
nary medicines and feeds prepared from 100 percent natural herbal ingredients. A
s an industry leader in agricultural processing, Sunwin has built an integrated
global firm with the sourcing and production capabilities to meet the needs of c
onsumers throughout the world. Sunwin also makes such value-added products as sp
ecialty veterinary food ingredients and specialty feed ingredients. For more inf
o about Sunwin, please visit http://www.sunwininternational.com.

Safe Harbor Statement

Sunwin International Neutraceuticals, Inc., is hereby providing cautionary stat
ements identifying important factors that could cause our actual results to diff
er materially from those projected in forward-looking statements (as defined in
such act). Any statements that are not historical facts and that express, or inv
olve discussions as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance (often, but not always, indicated through the use
of words or phrases such as "will likely result," "are expected to," "will conti
nue," "is anticipated," "estimated," "intends," "plans," "believes" and "project
s") may be forward-looking and may involve estimates and uncertainties which cou
ld cause actual results to differ materially from those expressed in the forward
-looking statements. These statements include, but are not limited to, our guida
nce and expectations regarding revenues, net income and earnings.
We caution that the factors described herein could cause actual results to diff
er materially from those expressed in any forward-looking statements we make and
that investors should not place undue reliance on any such forward-looking stat
ements. Further, any forward-looking statement speaks only as of the date on whi
ch such statement is made, and we undertake no obligation to update any forward-
looking statement to reflect events or circumstances after the date on which suc
h statement is made or to reflect the occurrence of anticipated or unanticipated
events or circumstances. New factors emerge from time to time, and it is not po
ssible for us to predict all of such factors. Further, we cannot assess the impa
ct of each such factor on our results of operations or the extent to which any f
actor, or combination of factors, may cause actual results to differ materially
from those contained in any forward-looking statements. This press release is qu
alified in its entirety by the cautionary statements and risk factor disclosure
contained in our Securities and Exchange Commission filings, including our Annua
l Report on Form 10-K for the fiscal year ended April 30, 2009.

CONTACT: Company: Jeff Reynolds, [phone], [e-mail]; Inves
tors: Matt Kreps, The Shelton Group, [phone] ext 125, mkreps@sheltongroup
.com

SOURCE Sunwin International Neutraceuticals Inc.


Contact Information:
Company: Jeff Reynolds, [phone], [e-mail]; Investors: Matt
*** end of story ***oup, [phone] ext 125, [e-mail]

[V51]